Catalyst Wire Dossier Catalyst Wire Dossier

N-GAL

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N-GAL, covering 2013-03-07 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy [Phase 4]

See pricing